BIO Stock Ownership Activity

BIO-RAD LABORATORIES-A 13F holders

2 value investing gurus have made changes to the BIO-RAD LABORATORIES-A (BIO) position according to the gurus' latest SEC quarterly report(s). BIO has been completely sold out by 1 guru(s), the number of BIO shares has been increased by 1 super investor(s).

Which gurus or hedge funds are buying BIO now?

According to the latest SEC filing(s) BIO-RAD LABORATORIES-A (BIO) has been bought by John W. Rogers Jr. - Ariel Appreciation Fund (added shares +29.05%).

To see more about who is investing in BIO-RAD LABORATORIES-A (BIO), please go to the BIO ownership page.

History
Name
Company
%
Activity
Share
Change
% change to
Portfolio
% of
Portfolio
2024 Q3 (2 results)
John W. Rogers Jr.
Ariel Appreciation Fund
+29.05%
+13,071
+0.50%
1.92%
Nathaniel Simons
Meritage Group
-100.00%
-1,180
-0.01%
0.00%
Current price: $327.47 2.13% AVG reported price*: $334.58
2024 Q2 (3 results)
Nathaniel Simons
Meritage Group
+56.08%
+424
+0.00%
0.00%
John W. Rogers Jr.
Ariel Appreciation Fund
+51.36%
+17,548
+0.50%
1.47%
Parnassus Investments
Parnassus Endeavor Fund
+30.67%
+72,942
+0.41%
1.73%
Current price: $327.47 19.90% AVG reported price*: $273.11
2024 Q1 (2 results)
John W. Rogers Jr.
Ariel Appreciation Fund
buy
+34,165
+1.10%
1.10%
Nathaniel Simons
Meritage Group
-7.47%
-31
-0.00%
0.00%
Current price: $327.47 5.25% AVG reported price*: $345.61
2023 Q4 (3 results)
Nathaniel Simons
Meritage Group
buy
+817
+0.01%
0.01%
Mason Hawkins
Longleaf Partners
+14.53%
+24,982
+0.68%
5.33%
Parnassus Investments
Parnassus Endeavor Fund
+7.70%
+16,999
+0.11%
1.56%
Current price: $327.47 1.39% AVG reported price*: $322.97
2023 Q3 (3 results)
Mason Hawkins
Longleaf Partners
buy
+100,612
+5.02%
2.94%
Parnassus Investments
Parnassus Endeavor Fund
buy
+220,791
+1.74%
1.74%
Nathaniel Simons
Meritage Group
-100.00%
-640
-0.01%
0.00%
Current price: $327.47 8.64% AVG reported price*: $358.45
2023 Q2 (1 result)
Nathaniel Simons
Meritage Group
buy
+640
+0.01%
0.00%
Current price: $327.47 13.49% Reported price*: $378.52
2022 Q3 (1 result)
Nathaniel Simons
Meritage Group
-100.00%
-469
-0.01%
0.00%
Current price: $327.47 33.80% Reported price*: $494.67
2022 Q2 (1 result)
Nathaniel Simons
Meritage Group
-40.86%
-324
-0.00%
0.00%
Current price: $327.47 33.80% Reported price*: $494.67
2022 Q1 (1 result)
Nathaniel Simons
Meritage Group
-22.41%
-229
-0.00%
0.01%
Current price: $327.47 41.91% Reported price*: $563.68
2021 Q4 (1 result)
Nathaniel Simons
Meritage Group
+124.12%
+367
+0.01%
0.01%
Current price: $327.47 56.67% Reported price*: $755.72
2021 Q3 (1 result)
Nathaniel Simons
Meritage Group
-47.65%
-415
-0.01%
0.01%
Current price: $327.47 56.08% Reported price*: $745.61
2021 Q2 (1 result)
Nathaniel Simons
Meritage Group
+19.48%
+142
+0.00%
0.01%
Current price: $327.47 49.16% Reported price*: $644.09
2021 Q1 (1 result)
Nathaniel Simons
Meritage Group
+8.48%
+57
+0.00%
0.01%
Current price: $327.47 42.61% Reported price*: $570.64
2020 Q4 (1 result)
Nathaniel Simons
Meritage Group
-11.70%
-89
-0.00%
0.01%
Current price: $327.47 43.86% Reported price*: $583.33
2020 Q3 (1 result)
Nathaniel Simons
Meritage Group
buy
+761
+0.01%
0.01%
Current price: $327.47 36.43% Reported price*: $515.11
23 of 23

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.